Cardiovascular Health, as per Life's Essential 8, and Impaired Lower-Extremity Function in Older Adults.

IF 7 2区 医学 Q1 GERIATRICS & GERONTOLOGY
David Gómez-Ángel, Mercedes Sotos-Prieto, David Martínez-Gómez, Auxiliadora Graciani, Esther García-Esquinas, Fernando Rodríguez-Artalejo, Rosario Ortolá
{"title":"Cardiovascular Health, as per Life's Essential 8, and Impaired Lower-Extremity Function in Older Adults.","authors":"David Gómez-Ángel, Mercedes Sotos-Prieto, David Martínez-Gómez, Auxiliadora Graciani, Esther García-Esquinas, Fernando Rodríguez-Artalejo, Rosario Ortolá","doi":"10.14336/AD.2025.0347","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiovascular health (CVH) is a broad construct that encompasses multiple behavioral and biological factors. A decline in CVH has been associated with various adverse health outcomes, but its role in impaired lower-extremity function (ILEF), a major contributor to disability, diminished quality of life and mortality in older adults, is unknown. Therefore, we examined the cross-sectional and prospective association between CVH and lower-extremity function. Using data from 2,487 individuals aged ≥65y from the Seniors-ENRICA-2 cohort, we estimated CVH at baseline using the American Heart Association's Life's Essential 8 (LE8) score (range 0 to 100, with higher values indicating better CVH). We assessed ILEF at baseline and at 2.4-year and 5.2-year follow-ups using the Short Physical Performance Battery (SPPB). Statistical analyses were conducted with logistic regression with adjustment for the main confounders. ILEF was present in 26.8% of participants at baseline (666 events). The cumulative incidence over 2.4 and 5.2 years was 24.8% (278 events) and 22.5% (157 events), respectively. A 10-point higher LE8 score at baseline was associated with lower prevalence of ILEF (SPPB ≤9) at baseline (odds ratio [OR] 0.75, 95% confidence interval [CI]: 0.69-0.80), and lower risk of incident ILEF over 2.4 years (OR 0.77, 95% CI: 0.68-0.87) and 5.2 years (OR 0.76, 95% CI: 0.65-0.89). Physical activity, glucose levels, body mass index and nicotine exposure stood out as major contributors to the lower risk of incident ILEF associated with a higher LE8 score. A higher LE8 score was associated with both a lower prevalence and incidence of ILEF in older adults. Comprehensive evaluation of CVH offers insight into older adults' lower-extremity function and how it may progress over time, identifying opportunities for early intervention.</p>","PeriodicalId":7434,"journal":{"name":"Aging and Disease","volume":" ","pages":""},"PeriodicalIF":7.0000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging and Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14336/AD.2025.0347","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiovascular health (CVH) is a broad construct that encompasses multiple behavioral and biological factors. A decline in CVH has been associated with various adverse health outcomes, but its role in impaired lower-extremity function (ILEF), a major contributor to disability, diminished quality of life and mortality in older adults, is unknown. Therefore, we examined the cross-sectional and prospective association between CVH and lower-extremity function. Using data from 2,487 individuals aged ≥65y from the Seniors-ENRICA-2 cohort, we estimated CVH at baseline using the American Heart Association's Life's Essential 8 (LE8) score (range 0 to 100, with higher values indicating better CVH). We assessed ILEF at baseline and at 2.4-year and 5.2-year follow-ups using the Short Physical Performance Battery (SPPB). Statistical analyses were conducted with logistic regression with adjustment for the main confounders. ILEF was present in 26.8% of participants at baseline (666 events). The cumulative incidence over 2.4 and 5.2 years was 24.8% (278 events) and 22.5% (157 events), respectively. A 10-point higher LE8 score at baseline was associated with lower prevalence of ILEF (SPPB ≤9) at baseline (odds ratio [OR] 0.75, 95% confidence interval [CI]: 0.69-0.80), and lower risk of incident ILEF over 2.4 years (OR 0.77, 95% CI: 0.68-0.87) and 5.2 years (OR 0.76, 95% CI: 0.65-0.89). Physical activity, glucose levels, body mass index and nicotine exposure stood out as major contributors to the lower risk of incident ILEF associated with a higher LE8 score. A higher LE8 score was associated with both a lower prevalence and incidence of ILEF in older adults. Comprehensive evaluation of CVH offers insight into older adults' lower-extremity function and how it may progress over time, identifying opportunities for early intervention.

心血管健康,根据生活的基本8,和老年人的下肢功能受损。
心血管健康(CVH)是一个广泛的结构,包括多种行为和生物因素。CVH的下降与各种不良健康结果有关,但其在下肢功能受损(ILEF)中的作用尚不清楚,而下肢功能受损是老年人残疾、生活质量下降和死亡率的主要原因。因此,我们研究了CVH与下肢功能之间的横断面和前瞻性关联。使用来自senior - enrica -2队列的2487名年龄≥65岁的个体的数据,我们使用美国心脏协会的生命基本8 (LE8)评分(范围从0到100,数值越高表明CVH越好)来估计基线时的CVH。我们使用短物理性能电池(SPPB)在基线和2.4年和5.2年随访时评估ILEF。采用逻辑回归进行统计分析,并对主要混杂因素进行校正。基线时,26.8%的参与者存在ILEF(666次)。2.4年和5.2年的累计发病率分别为24.8%(278例)和22.5%(157例)。基线时LE8评分高10分与基线时ILEF患病率(SPPB≤9)降低相关(比值比[OR] 0.75, 95%可信区间[CI]: 0.69-0.80), 2.4年(OR 0.77, 95% CI: 0.68-0.87)和5.2年(OR 0.76, 95% CI: 0.65-0.89)发生ILEF的风险降低相关。体力活动、血糖水平、体重指数和尼古丁暴露是导致低发生率与高LE8评分相关的ILEF的主要因素。较高的LE8评分与老年人中较低的ILEF患病率和发病率相关。CVH的综合评估可以深入了解老年人的下肢功能及其随时间的发展情况,从而确定早期干预的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Aging and Disease
Aging and Disease GERIATRICS & GERONTOLOGY-
CiteScore
14.60
自引率
2.70%
发文量
138
审稿时长
10 weeks
期刊介绍: Aging & Disease (A&D) is an open-access online journal dedicated to publishing groundbreaking research on the biology of aging, the pathophysiology of age-related diseases, and innovative therapies for conditions affecting the elderly. The scope encompasses various diseases such as Stroke, Alzheimer's disease, Parkinson’s disease, Epilepsy, Dementia, Depression, Cardiovascular Disease, Cancer, Arthritis, Cataract, Osteoporosis, Diabetes, and Hypertension. The journal welcomes studies involving animal models as well as human tissues or cells.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信